Segmental facial infantile haemangiomas in the era of propranolol: evaluation at 6 years of age.
O LetertreOlivia BoccaraSorilla PreyJ-M PedespanF BoraleviC Léauté-LabrèzePublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
In this case series, children with SFIH, including patients with PHACES criteria, presented a good tolerance of propranolol, as well as encouraged neurodevelopmental data. Segmental implication appears to have a significant impact on treatment duration and associated complications.